{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:44:53Z","timestamp":1790934293398,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03732-2","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T06:13:26Z","timestamp":1740809606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["An update on the molecular mechanisms underlying the progression of miR-21 in oral cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Monisha","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hamsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fareed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohmed Isaqail","family":"Karobari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"3732_CR1","doi-asserted-by":"publisher","unstructured":"Mohanprasanth A, Saravanan M. Advancements in cancer research: 3D Bioprinting as an optimal oral tumor model. Oral Oncol Rep. 2024;100174. https:\/\/doi.org\/10.1016\/j.oor.2024.100174.","DOI":"10.1016\/j.oor.2024.100174"},{"key":"3732_CR2","doi-asserted-by":"publisher","first-page":"1297752","DOI":"10.3389\/fonc.2024.1297752","volume":"14","author":"M Szewczyk","year":"2024","unstructured":"Szewczyk M, Pazdrowski J, Golusi\u0144ski P, Wi\u0119ckowska B, Golusi\u0144ski W. Oral cancer in young adults: should we approach these patients differently? Front Oncol. 2024;14:1297752. https:\/\/doi.org\/10.3389\/fonc.2024.1297752.","journal-title":"Front Oncol"},{"key":"3732_CR3","doi-asserted-by":"publisher","first-page":"106858","DOI":"10.1016\/j.oraloncology.2024.106858","volume":"154","author":"M Saravanan","year":"2024","unstructured":"Saravanan M, Carmelin DS, Mohanprasanth A, Arockiaraj J. Comment on oral Microbiome and risk of incident head and neck cancer: A nested case-control study. Oral Oncol. 2024;154:106858. https:\/\/doi.org\/10.1016\/j.oraloncology.2024.106858.","journal-title":"Oral Oncol"},{"key":"3732_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","volume":"87","author":"M Castaneda","year":"2022","unstructured":"Castaneda M, den Hollander P, Kuburich NA, Rosen JM, Mani SA. Mechanisms of cancer metastasis. Sem Cancer Biol. 2022;87:17\u201331. https:\/\/doi.org\/10.1016\/j.semcancer.2022.10.006.","journal-title":"Sem Cancer Biol"},{"key":"3732_CR5","doi-asserted-by":"publisher","first-page":"205031212110343","DOI":"10.1177\/20503121211034366","volume":"9","author":"DT Debela","year":"2021","unstructured":"Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, Kitui SK, Manyazewal T. New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med. 2021;9:20503121211034366. https:\/\/doi.org\/10.1177\/20503121211034366.","journal-title":"SAGE Open Med"},{"issue":"6","key":"3732_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.trecan.2022.02.007","volume":"8","author":"J Almagro","year":"2022","unstructured":"Almagro J, Messal HA, Elosegui-Artola A, van Rheenen J, Behrens A. Tissue architecture in tumor initiation and progression. Trends cancer. 2022;8(6):494\u2013505. https:\/\/doi.org\/10.1016\/j.trecan.2022.02.007.","journal-title":"Trends cancer"},{"issue":"6","key":"3732_CR7","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Investig. 2009;119(6):1420\u20138. https:\/\/doi.org\/10.1172\/JCI39104.","journal-title":"J Clin Investig"},{"key":"3732_CR8","doi-asserted-by":"publisher","first-page":"708765","DOI":"10.3389\/fonc.2021.708765","volume":"11","author":"K Otmani","year":"2021","unstructured":"Otmani K, Lewalle P. Tumor suppressor MiRNA in Cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol. 2021;11:708765. https:\/\/doi.org\/10.3389\/fonc.2021.708765.","journal-title":"Front Oncol"},{"issue":"13","key":"3732_CR9","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1080\/15384101.2014.1003008","volume":"14","author":"C Stahlhut","year":"2015","unstructured":"Stahlhut C, Slack FJ. Combinatorial action of MicroRNAs let-7 and miR-34 effectively synergizes with erlotinib to suppress Non-small cell lung Cancer cell proliferation. Cell Cycle (Georgetown Tex). 2015;14(13):2171\u201380. https:\/\/doi.org\/10.1080\/15384101.2014.1003008.","journal-title":"Cell Cycle (Georgetown Tex)"},{"key":"3732_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","volume":"20","author":"D Bautista-S\u00e1nchez","year":"2020","unstructured":"Bautista-S\u00e1nchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Vel\u00e1zquez IA, Gonz\u00e1lez-Barrios R, Contreras-Espinosa L, Montiel-Manr\u00edquez R, Castro-Hern\u00e1ndez C, Fragoso-Ontiveros V, \u00c1lvarez-G\u00f3mez RM, Herrera LA. The promising role of miR-21 as a Cancer biomarker and its importance in RNA-Based therapeutics. Mol Therapy Nucleic Acids. 2020;20:409\u201320. https:\/\/doi.org\/10.1016\/j.omtn.2020.03.003.","journal-title":"Mol Therapy Nucleic Acids"},{"key":"3732_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402. https:\/\/doi.org\/10.3389\/fendo.2018.00402.","journal-title":"Front Endocrinol"},{"issue":"1","key":"3732_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2023.2288741","volume":"21","author":"X Bofill-De Ros","year":"2024","unstructured":"Bofill-De Ros X, Vang \u00d8rom UA. Recent progress in MiRNA biogenesis and decay. RNA Biol. 2024;21(1):1\u20138. https:\/\/doi.org\/10.1080\/15476286.2023.2288741.","journal-title":"RNA Biol"},{"issue":"5","key":"3732_CR13","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.molcel.2020.10.028","volume":"80","author":"GM Rice","year":"2020","unstructured":"Rice GM, Shivashankar V, Ma EJ, Baryza JL, Nutiu R. Functional atlas of primary MiRNA maturation by the microprocessor. Mol Cell. 2020;80(5):892\u2013e9024. https:\/\/doi.org\/10.1016\/j.molcel.2020.10.028.","journal-title":"Mol Cell"},{"issue":"10","key":"3732_CR14","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1111\/febs.16422","volume":"290","author":"P Naeli","year":"2023","unstructured":"Naeli P, Winter T, Hackett AP, Alboushi L, Jafarnejad SM. The intricate balance between microRNA-induced mRNA decay and translational repression. FEBS J. 2023;290(10):2508\u201324. https:\/\/doi.org\/10.1111\/febs.16422.","journal-title":"FEBS J"},{"issue":"3","key":"3732_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12033-007-9013-8","volume":"38","author":"SY Ying","year":"2008","unstructured":"Ying SY, Chang DC, Lin SL. The MicroRNA (miRNA): overview of the RNA genes that modulate gene function. Mol Biotechnol. 2008;38(3):257\u201368. https:\/\/doi.org\/10.1007\/s12033-007-9013-8.","journal-title":"Mol Biotechnol"},{"issue":"18","key":"3732_CR16","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.3390\/cells11182791","volume":"11","author":"J Rhim","year":"2022","unstructured":"Rhim J, Baek W, Seo Y, Kim JH. From molecular mechanisms to therapeutics: Understanding MicroRNA-21 in Cancer. Cells. 2022;11(18):2791. https:\/\/doi.org\/10.3390\/cells11182791.","journal-title":"Cells"},{"issue":"10","key":"3732_CR17","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/ijms17101712","volume":"17","author":"C Catalanotto","year":"2016","unstructured":"Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci. 2016;17(10):1712. https:\/\/doi.org\/10.3390\/ijms17101712.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3732_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","volume":"15","author":"M Ratti","year":"2020","unstructured":"Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, Hahne JC. MicroRNAs (miRNAs) and long Non-Coding RNAs (lncRNAs) as new tools for Cancer therapy: first steps from bench to bedside. Target Oncol. 2020;15(3):261\u201378. https:\/\/doi.org\/10.1007\/s11523-020-00717-x.","journal-title":"Target Oncol"},{"issue":"7","key":"3732_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138920210793175895","volume":"11","author":"LA Macfarlane","year":"2010","unstructured":"Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in Cancer. Curr Genom. 2010;11(7):537\u201361. https:\/\/doi.org\/10.2174\/138920210793175895.","journal-title":"Curr Genom"},{"issue":"10","key":"3732_CR20","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/bioinformatics\/btr149","volume":"27","author":"DC Ellwanger","year":"2011","unstructured":"Ellwanger DC, B\u00fcttner FA, Mewes HW, St\u00fcmpflen V. The sufficient minimal set of MiRNA seed types. Bioinf (Oxford England). 2011;27(10):1346\u201350. https:\/\/doi.org\/10.1093\/bioinformatics\/btr149.","journal-title":"Bioinf (Oxford England)"},{"key":"3732_CR21","doi-asserted-by":"publisher","first-page":"832916","DOI":"10.3389\/fmolb.2022.832916","volume":"9","author":"CF Jungers","year":"2022","unstructured":"Jungers CF, Djuranovic S. Modulation of miRISC-Mediated gene Silencing in eukaryotes. Front Mol Biosci. 2022;9:832916. https:\/\/doi.org\/10.3389\/fmolb.2022.832916.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"3732_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Tang X, Chen Y, Chen K, Fan N, Xiao W, Zheng Q, Li G, Teng Y, Wu M, Song X. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct Target Therapy. 2022;7(1):166. https:\/\/doi.org\/10.1038\/s41392-022-01007-w.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"3732_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2021.11.026","volume":"82","author":"HO Iwakawa","year":"2022","unstructured":"Iwakawa HO, Tomari Y. Life of RISC: formation, action, and degradation of RNA-induced Silencing complex. Mol Cell. 2022;82(1):30\u201343. https:\/\/doi.org\/10.1016\/j.molcel.2021.11.026.","journal-title":"Mol Cell"},{"issue":"6","key":"3732_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41580-019-0118-2","volume":"20","author":"CAP Joazeiro","year":"2019","unstructured":"Joazeiro CAP. Mechanisms and functions of ribosome-associated protein quality control. Nat Rev Mol Cell Biol. 2019;20(6):368\u201383. https:\/\/doi.org\/10.1038\/s41580-019-0118-2.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3732_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1261\/rna.1399509","volume":"15","author":"A Eulalio","year":"2009","unstructured":"Eulalio A, Huntzinger E, Nishihara T, Rehwinkel J, Fauser M, Izaurralde E. Deadenylation is a widespread effect of MiRNA regulation. RNA (New York N Y). 2009;15(1):21\u201332. https:\/\/doi.org\/10.1261\/rna.1399509.","journal-title":"RNA (New York N Y)"},{"issue":"12","key":"3732_CR26","doi-asserted-by":"publisher","first-page":"a012328","DOI":"10.1101\/cshperspect.a012328","volume":"4","author":"JE Braun","year":"2012","unstructured":"Braun JE, Huntzinger E, Izaurralde E. A molecular link between MiRISCs and deadenylases provides new insight into the mechanism of gene Silencing by MicroRNAs. Cold Spring Harb Perspect Biol. 2012;4(12):a012328. https:\/\/doi.org\/10.1101\/cshperspect.a012328.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3732_CR27","doi-asserted-by":"publisher","first-page":"106568","DOI":"10.1016\/j.phrs.2022.106568","volume":"187","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, Daneii P, Gholami S, Ghorbani A, Tavakolpournegari A, Farsani ZM, Zarrabi A, Nabavi N, Zandieh MA, Rashidi M, Taheriazam A, Entezari M, Khan H. Pre-clinical and clinical importance of miR-21 in human cancers: tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacol Res. 2023;187:106568. https:\/\/doi.org\/10.1016\/j.phrs.2022.106568.","journal-title":"Pharmacol Res"},{"issue":"2","key":"3732_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/cells14020091","volume":"14","author":"M Jaksic Karisik","year":"2025","unstructured":"Jaksic Karisik M, Lazarevic M, Mitic D, Milosevic Markovic M, Riberti N, Jelovac D, Milasin J. MicroRNA-21 as a regulator of Cancer stem cell properties in oral Cancer. Cells. 2025;14(2):91. https:\/\/doi.org\/10.3390\/cells14020091.","journal-title":"Cells"},{"issue":"16","key":"3732_CR29","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.3390\/cancers13163949","volume":"13","author":"F Rascio","year":"2021","unstructured":"Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, Ranieri E. The pathogenic role of PI3K\/AKT pathway in Cancer onset and drug resistance: an updated review. Cancers. 2021;13(16):3949. https:\/\/doi.org\/10.3390\/cancers13163949.","journal-title":"Cancers"},{"issue":"1","key":"3732_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13046-018-0898-9","volume":"37","author":"W Li","year":"2018","unstructured":"Li W, Zhang T, Guo L, Huang L. Regulation of PTEN expression by non-coding RNAs. J Experimental Clin cancer Research: CR. 2018;37(1):223. https:\/\/doi.org\/10.1186\/s13046-018-0898-9.","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"15","key":"3732_CR31","doi-asserted-by":"publisher","first-page":"e34950","DOI":"10.1016\/j.heliyon.2024.e34950","volume":"10","author":"F Bergez-Hern\u00e1ndez","year":"2024","unstructured":"Bergez-Hern\u00e1ndez F, Irigoyen-Arredondo M, Mart\u00ednez-Camberos A. A systematic review of mechanisms of PTEN gene down-regulation mediated by MiRNA in prostate cancer. Heliyon. 2024;10(15):e34950. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34950.","journal-title":"Heliyon"},{"issue":"9","key":"3732_CR32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Li W, Hu J, Lu C, Liu Y. PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 2020;11(9):797. https:\/\/doi.org\/10.1038\/s41419-020-02998-6.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3732_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, Kulke MH, Baird RD, Prabhu JS, Carbone D, Pecoraro C, Teh DBL, Sethi G, Cavalieri V, Lin KH, Javidi-Sharifi NR, Kumar AP. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"issue":"1","key":"3732_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12967-024-05411-4","volume":"22","author":"AO Giarratana","year":"2024","unstructured":"Giarratana AO, Prendergast CM, Salvatore MM, Capaccione KM. TGF-\u03b2 signaling: critical nexus of fibrogenesis and cancer. J Translational Med. 2024;22(1):594. https:\/\/doi.org\/10.1186\/s12967-024-05411-4.","journal-title":"J Translational Med"},{"issue":"1","key":"3732_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/jcm5010008","volume":"5","author":"ML Abba","year":"2016","unstructured":"Abba ML, Patil N, Leupold JH, Allgayer H. MicroRNA regulation of epithelial to mesenchymal transition. J Clin Med. 2016;5(1):8. https:\/\/doi.org\/10.3390\/jcm5010008.","journal-title":"J Clin Med"},{"key":"3732_CR36","doi-asserted-by":"publisher","first-page":"707461","DOI":"10.3389\/fmolb.2021.707461","volume":"8","author":"X Xu","year":"2021","unstructured":"Xu X, Hong P, Wang Z, Tang Z, Li K. MicroRNAs in transforming growth Factor-Beta signaling pathway associated with fibrosis involving different systems of the human body. Front Mol Biosci. 2021;8:707461. https:\/\/doi.org\/10.3389\/fmolb.2021.707461.","journal-title":"Front Mol Biosci"},{"key":"3732_CR37","doi-asserted-by":"publisher","first-page":"109993","DOI":"10.1016\/j.cellsig.2021.109993","volume":"83","author":"JJ Russell","year":"2021","unstructured":"Russell JJ, Grisanti LA, Brown SM, Bailey CA, Bender SB, Chandrasekar B. Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: the recklessness of adverse remodeling. Cell Signal. 2021;83:109993. https:\/\/doi.org\/10.1016\/j.cellsig.2021.109993.","journal-title":"Cell Signal"},{"key":"3732_CR38","doi-asserted-by":"publisher","first-page":"101746","DOI":"10.1016\/j.toxrep.2024.101746","volume":"13","author":"S Srinivasan","year":"2024","unstructured":"Srinivasan S, Mohanprasanth A, Nadeem A, Saravanan M. Exploring the anti-cancer and antimetastatic effect of Silymarin against lung cancer. Toxicol Rep. 2024;13:101746. https:\/\/doi.org\/10.1016\/j.toxrep.2024.101746.","journal-title":"Toxicol Rep"},{"issue":"3","key":"3732_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajg.2019.07.003","volume":"20","author":"J Wang","year":"2019","unstructured":"Wang J, Lin Y, Jiang T, Gao C, Wang D, Wang X, Wei Y, Liu T, Zhu L, Wang P, Qi F. Up-regulation of TIMP-3 and RECK decrease the invasion and metastasis ability of colon cancer. Arab J Gastroenterology: Official Publication Pan-Arab Association Gastroenterol. 2019;20(3):127\u201334. https:\/\/doi.org\/10.1016\/j.ajg.2019.07.003.","journal-title":"Arab J Gastroenterology: Official Publication Pan-Arab Association Gastroenterol"},{"issue":"17","key":"3732_CR40","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1128\/MCB.00479-08","volume":"28","author":"G Gabriely","year":"2008","unstructured":"Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 2008;28(17):5369\u201380. https:\/\/doi.org\/10.1128\/MCB.00479-08.","journal-title":"Mol Cell Biol"},{"issue":"41","key":"3732_CR41","doi-asserted-by":"publisher","first-page":"66989","DOI":"10.18632\/oncotarget.11888","volume":"7","author":"C Li","year":"2016","unstructured":"Li C, Song L, Zhang Z, Bai XX, Cui MF, Ma LJ. MicroRNA-21 promotes TGF-\u03b21-induced epithelial-mesenchymal transition in gastric cancer through upregulating PTEN expression. Oncotarget. 2016;7(41):66989\u20137003. https:\/\/doi.org\/10.18632\/oncotarget.11888.","journal-title":"Oncotarget"},{"issue":"4","key":"3732_CR42","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/mco2.104","volume":"2","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-\u03baB signaling in inflammation and cancer. MedComm. 2021;2(4):618\u201353. https:\/\/doi.org\/10.1002\/mco2.104.","journal-title":"MedComm"},{"issue":"2","key":"3732_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/biomedicines6020040","volume":"6","author":"GS Markopoulos","year":"2018","unstructured":"Markopoulos GS, Roupakia E, Tokamani M, Alabasi G, Sandaltzopoulos R, Marcu KB, Kolettas E. Roles of NF-\u03baB signaling in the regulation of MiRNAs impacting on inflammation in Cancer. Biomedicines. 2018;6(2):40. https:\/\/doi.org\/10.3390\/biomedicines6020040.","journal-title":"Biomedicines"},{"key":"3732_CR44","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2147\/COPD.S453593","volume":"19","author":"X Sai","year":"2024","unstructured":"Sai X, Qin C, Zhang Z, Yu H, Bian T. A miRNA-21-Mediated PTEN\/Akt\/NF-\u03baB Axis promotes chronic obstructive pulmonary disease pathogenesis. Int J Chronic Obstr Pulm Dis. 2024;19:1141\u201351. https:\/\/doi.org\/10.2147\/COPD.S453593.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"3","key":"3732_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jmcb\/mjr007","volume":"3","author":"X Ma","year":"2011","unstructured":"Ma X, Buscaglia B, Barker LE, J. R., Li Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol. 2011;3(3):159\u201366. https:\/\/doi.org\/10.1093\/jmcb\/mjr007.","journal-title":"J Mol Cell Biol"},{"key":"3732_CR46","doi-asserted-by":"publisher","first-page":"113951","DOI":"10.1016\/j.biopha.2022.113951","volume":"156","author":"C Guan","year":"2022","unstructured":"Guan C, Zhou X, Li H, Ma X, Zhuang J. NF-\u03baB inhibitors gifted by nature: the anticancer promise of polyphenol compounds. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2022;156:113951. https:\/\/doi.org\/10.1016\/j.biopha.2022.113951.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"12","key":"3732_CR47","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.neo.2021.10.003","volume":"23","author":"I To\u0161i\u0107","year":"2021","unstructured":"To\u0161i\u0107 I, Frank DA. STAT3 as a mediator of oncogenic cellular metabolism: pathogenic and therapeutic implications. Neoplasia (New York N Y). 2021;23(12):1167\u201378. https:\/\/doi.org\/10.1016\/j.neo.2021.10.003.","journal-title":"Neoplasia (New York N Y)"},{"issue":"4","key":"3732_CR48","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.gendis.2021.10.009","volume":"9","author":"M Sajjadi-Dokht","year":"2021","unstructured":"Sajjadi-Dokht M, Mohamad M, Sulaiman Rahman TA, Suliman Maashi H, Danshina M, Shomali S, Solali N, Marofi S, Zeinalzadeh F, Akbari E, Adili M, Aslaminabad A, Farshdousti Hagh R, M., Jarahian M. MicroRNAs and JAK\/STAT3 signaling: A new promising therapeutic axis in blood cancers. Genes Dis. 2021;9(4):849\u201367. https:\/\/doi.org\/10.1016\/j.gendis.2021.10.009.","journal-title":"Genes Dis"},{"key":"3732_CR49","doi-asserted-by":"publisher","first-page":"883683","DOI":"10.3389\/fimmu.2022.883683","volume":"13","author":"L Liang","year":"2022","unstructured":"Liang L, Xu X, Li J, Yang C. Interaction between MicroRNAs and Myeloid-Derived suppressor cells in tumor microenvironment. Front Immunol. 2022;13:883683. https:\/\/doi.org\/10.3389\/fimmu.2022.883683.","journal-title":"Front Immunol"},{"issue":"2","key":"3732_CR50","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/cancers14020264","volume":"14","author":"J Tse","year":"2022","unstructured":"Tse J, Pierce T, Carli ALE, Alorro MG, Thiem S, Marcusson EG, Ernst M, Buchert M. Onco-miR-21 promotes Stat3-Dependent gastric Cancer progression. Cancers. 2022;14(2):264. https:\/\/doi.org\/10.3390\/cancers14020264.","journal-title":"Cancers"},{"issue":"1","key":"3732_CR51","doi-asserted-by":"publisher","first-page":"134","DOI":"10.7150\/ijbs.50773","volume":"17","author":"C Shan","year":"2021","unstructured":"Shan C, Chen X, Cai H, Hao X, Li J, Zhang Y, Gao J, Zhou Z, Li X, Liu C, Li P, Wang K. The emerging roles of Autophagy-Related MicroRNAs in Cancer. Int J Biol Sci. 2021;17(1):134\u201350. https:\/\/doi.org\/10.7150\/ijbs.50773.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"3732_CR52","doi-asserted-by":"publisher","first-page":"8474","DOI":"10.18632\/oncotarget.3523","volume":"6","author":"Z Su","year":"2015","unstructured":"Su Z, Yang Z, Xu Y, Chen Y, Yu Q. MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget. 2015;6(11):8474\u201390. https:\/\/doi.org\/10.18632\/oncotarget.3523.","journal-title":"Oncotarget"},{"key":"3732_CR53","doi-asserted-by":"publisher","first-page":"841625","DOI":"10.3389\/fonc.2022.841625","volume":"12","author":"Y Lei","year":"2022","unstructured":"Lei Y, Chen L, Liu J, Zhong Y, Deng L. The MicroRNA-Based strategies to combat Cancer chemoresistance via regulating autophagy. Front Oncol. 2022;12:841625. https:\/\/doi.org\/10.3389\/fonc.2022.841625.","journal-title":"Front Oncol"},{"issue":"6","key":"3732_CR54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5732\/cjc.011.10132","volume":"30","author":"LE Buscaglia","year":"2011","unstructured":"Buscaglia LE, Li Y. Apoptosis and the target genes of microRNA-21. Chin J cancer. 2011;30(6):371\u201380. https:\/\/doi.org\/10.5732\/cjc.011.10132.","journal-title":"Chin J cancer"},{"issue":"2","key":"3732_CR55","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1074\/jbc.M707224200","volume":"283","author":"LB Frankel","year":"2008","unstructured":"Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the MicroRNA miR-21 in breast cancer cells. J Biol Chem. 2008;283(2):1026\u201333. https:\/\/doi.org\/10.1074\/jbc.M707224200.","journal-title":"J Biol Chem"},{"issue":"54","key":"3732_CR56","doi-asserted-by":"publisher","first-page":"92914","DOI":"10.18632\/oncotarget.21656","volume":"8","author":"H Wu","year":"2017","unstructured":"Wu H, Wang J, Ma H, Xiao Z, Dong X. MicroRNA-21 inhibits mitochondria-mediated apoptosis in keloid. Oncotarget. 2017;8(54):92914\u201325. https:\/\/doi.org\/10.18632\/oncotarget.21656.","journal-title":"Oncotarget"},{"key":"3732_CR57","doi-asserted-by":"publisher","first-page":"1390704","DOI":"10.3389\/fcell.2024.1390704","volume":"12","author":"AS Abdul Manap","year":"2024","unstructured":"Abdul Manap AS, Wisham AA, Wong FW, Najmi A, Ng HR, Z. F., Diba RS. Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies. Front Cell Dev Biology. 2024;12:1390704. https:\/\/doi.org\/10.3389\/fcell.2024.1390704.","journal-title":"Front Cell Dev Biology"},{"issue":"1","key":"3732_CR58","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/s12885-019-5951-3","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang H, Tan Z, Hu H, Liu H, Wu T, Zheng C, Wang X, Luo Z, Wang J, Liu S, Lu Z, Tu J. microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC Cancer. 2019;19(1):738. https:\/\/doi.org\/10.1186\/s12885-019-5951-3.","journal-title":"BMC Cancer"},{"issue":"4","key":"3732_CR59","first-page":"692","volume":"13","author":"H Li","year":"2020","unstructured":"Li H, Zhao J, Jia X, Zhang Y, Du Y, Li H, Ma L, Huang J. miR-21 promotes growth, invasion and migration of lung cancer cells by AKT\/P-AKT\/cleaved-caspase 3\/MMP-2\/MMP-9 signaling pathway. Int J Clin Exp Pathol. 2020;13(4):692\u2013700.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"3732_CR60","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3892\/ol.2018.9864","volume":"17","author":"C You","year":"2019","unstructured":"You C, Jin L, Xu Q, Shen B, Jiao X, Huang X. Expression of miR-21 and miR-138 in colon cancer and its effect on cell proliferation and prognosis. Oncol Lett. 2019;17(2):2271\u20137. https:\/\/doi.org\/10.3892\/ol.2018.9864.","journal-title":"Oncol Lett"},{"issue":"12","key":"3732_CR61","first-page":"5668","volume":"12","author":"A Ali","year":"2022","unstructured":"Ali A, Jamieson NB, Khan IN, Chang D, Giovannetti E, Funel N, Frampton AE, Morton J, Sansom O, Evans TRJ, Duthie F, McKay CJ, Samra J, Gill AJ, Biankin A, Oien KA. Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter study of 686 patients. Am J cancer Res. 2022;12(12):5668\u201383.","journal-title":"Am J cancer Res"},{"issue":"21","key":"3732_CR62","doi-asserted-by":"publisher","first-page":"19127","DOI":"10.1074\/jbc.M110.216887","volume":"286","author":"C Gong","year":"2011","unstructured":"Gong C, Yao Y, Wang Y, Liu B, Wu W, Chen J, Su F, Yao H, Song E. Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem. 2011;286(21):19127\u201337. https:\/\/doi.org\/10.1074\/jbc.M110.216887.","journal-title":"J Biol Chem"},{"key":"3732_CR63","doi-asserted-by":"publisher","first-page":"103092","DOI":"10.1016\/j.amsu.2021.103092","volume":"73","author":"A Amiruddin","year":"2021","unstructured":"Amiruddin A, Massi MN, Islam AA, Patellongi I, Pratama MY, Sutandyo N, Natzir R, Hatta M, Latar M, N. H., Wahid S. microRNA-221 and Tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study. Annals Med Surg (2012). 2021;73:103092. https:\/\/doi.org\/10.1016\/j.amsu.2021.103092.","journal-title":"Annals Med Surg (2012)"},{"issue":"21","key":"3732_CR64","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.3390\/cancers14215326","volume":"14","author":"V Fogazzi","year":"2022","unstructured":"Fogazzi V, Kapahnke M, Cataldo A, Plantamura I, Tagliabue E, Di Cosimo S, Cosentino G, Iorio MV. The role of MicroRNAs in HER2-Positive breast cancer: where we are and future prospective. Cancers. 2022;14(21):5326. https:\/\/doi.org\/10.3390\/cancers14215326.","journal-title":"Cancers"},{"issue":"3","key":"3732_CR65","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.3892\/ol.2019.9941","volume":"17","author":"K Yang","year":"2019","unstructured":"Yang K, Wang S, Cheng Y, Tian Y, Hou J. Role of miRNA-21 in the diagnosis and prediction of treatment efficacy of primary central nervous system lymphoma. Oncol Lett. 2019;17(3):3475\u201381. https:\/\/doi.org\/10.3892\/ol.2019.9941.","journal-title":"Oncol Lett"},{"issue":"12","key":"3732_CR66","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3390\/jcm8122041","volume":"8","author":"AI Irimie-Aghiorghiesei","year":"2019","unstructured":"Irimie-Aghiorghiesei AI, Pop-Bica C, Pintea S, Braicu C, Cojocneanu R, Zim\u021ba AA, Gulei D, Slab\u00fd O, Berindan-Neagoe I. Prognostic value of MiR-21: an updated Meta-Analysis in head and neck squamous cell carcinoma (HNSCC). J Clin Med. 2019;8(12):2041. https:\/\/doi.org\/10.3390\/jcm8122041.","journal-title":"J Clin Med"},{"key":"3732_CR67","doi-asserted-by":"publisher","first-page":"516850","DOI":"10.3389\/fonc.2020.516850","volume":"10","author":"C Pop-Bica","year":"2020","unstructured":"Pop-Bica C, Pintea S, Magdo L, Cojocneanu R, Gulei D, Ferracin M, Berindan-Neagoe I. The clinical utility of miR-21 and let-7 in Non-small cell lung Cancer (NSCLC). A systematic review and Meta-Analysis. Front Oncol. 2020;10:516850. https:\/\/doi.org\/10.3389\/fonc.2020.516850.","journal-title":"Front Oncol"},{"key":"3732_CR68","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12935-020-01394-6","volume":"20","author":"SH Javanmard","year":"2020","unstructured":"Javanmard SH, Vaseghi G, Ghasemi A, Rafiee L, Ferns GA, Esfahani HN, Nedaeinia R. Therapeutic Inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in pre-clinical studies. Cancer Cell Int. 2020;20:384. https:\/\/doi.org\/10.1186\/s12935-020-01394-6.","journal-title":"Cancer Cell Int"},{"issue":"39","key":"3732_CR69","doi-asserted-by":"publisher","first-page":"7482","DOI":"10.1002\/anie.200801555","volume":"47","author":"K Gumireddy","year":"2008","unstructured":"Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q, Deiters A. Small-molecule inhibitors of Microrna miR-21 function. Angew Chem Int Ed Engl. 2008;47(39):7482\u20134. https:\/\/doi.org\/10.1002\/anie.200801555.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"3732_CR70","doi-asserted-by":"publisher","first-page":"e24527","DOI":"10.1002\/jcla.24527","volume":"36","author":"J Jie","year":"2022","unstructured":"Jie J, Liu D, Wang Y, Wu Q, Wu T, Fang R. Generation of MiRNA sponge constructs targeting multiple MiRNAs. J Clin Lab Anal. 2022;36(7):e24527. https:\/\/doi.org\/10.1002\/jcla.24527.","journal-title":"J Clin Lab Anal"},{"key":"3732_CR71","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.omtn.2018.09.004","volume":"13","author":"T Ding","year":"2018","unstructured":"Ding T, Cui P, Zhou Y, Chen C, Zhao J, Wang H, Guo M, He Z, Xu L. Antisense oligonucleotides against miR-21 inhibit the growth and metastasis of colorectal carcinoma via the DUSP8 pathway. Mol Therapy Nucleic Acids. 2018;13:244\u201355. https:\/\/doi.org\/10.1016\/j.omtn.2018.09.004.","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"2","key":"3732_CR72","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1021\/acschembio.2c00502","volume":"18","author":"MD Shortridge","year":"2023","unstructured":"Shortridge MD, Chaubey B, Zhang HJ, Pavelitz T, Vidadala V, Tang C, Olsen GL, Calin GA, Varani G. Drug-Like small molecules that inhibit expression of the oncogenic MicroRNA-21. ACS Chem Biol. 2023;18(2):237\u201350. https:\/\/doi.org\/10.1021\/acschembio.2c00502.","journal-title":"ACS Chem Biol"},{"issue":"6","key":"3732_CR73","doi-asserted-by":"publisher","first-page":"e39520","DOI":"10.1371\/journal.pone.0039520","volume":"7","author":"M Han","year":"2012","unstructured":"Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y, Wu C. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT\/ERK1\/2 inactivation by targeting PTEN. PLoS ONE. 2012;7(6):e39520. https:\/\/doi.org\/10.1371\/journal.pone.0039520. Epub 2012 Jun 25. PMID: 22761812; PMCID: PMC3382593.","journal-title":"PLoS ONE"},{"issue":"1","key":"3732_CR74","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3892\/ijo.2015.3232","volume":"48","author":"C Zhang","year":"2016","unstructured":"Zhang C, Liu K, Li T, Fang J, Ding Y, Sun L, Tu T, Jiang X, Du S, Hu J, Zhu W, Chen H, Sun X. miR-21: A gene of dual regulation in breast cancer. Int J Oncol. 2016;48(1):161\u201372. https:\/\/doi.org\/10.3892\/ijo.2015.3232.","journal-title":"Int J Oncol"},{"issue":"1","key":"3732_CR75","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/bcr2803","volume":"13","author":"LX Yan","year":"2011","unstructured":"Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, Zeng YX, Shao JY. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast cancer Research: BCR. 2011;13(1):R2. https:\/\/doi.org\/10.1186\/bcr2803.","journal-title":"Breast cancer Research: BCR"},{"issue":"11","key":"3732_CR76","doi-asserted-by":"publisher","first-page":"e0260327","DOI":"10.1371\/journal.pone.0260327","volume":"16","author":"A Amirfallah","year":"2021","unstructured":"Amirfallah A, Knutsdottir H, Arason A, Hilmarsdottir B, Johannsson OT, Agnarsson BA, Barkardottir RB, Reynisdottir I. Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways. PLoS ONE. 2021;16(11):e0260327. https:\/\/doi.org\/10.1371\/journal.pone.0260327.","journal-title":"PLoS ONE"},{"issue":"5","key":"3732_CR77","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00210-016-1224-8","volume":"389","author":"M Fragni","year":"2016","unstructured":"Fragni M, Bonini SA, Bettinsoli P, Bodei S, Generali D, Bottini A, Spano PF, Memo M, Sigala S. The miR-21\/PTEN\/Akt signaling pathway is involved in the anti-tumoral effects of Zoledronic acid in human breast cancer cell lines. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(5):529\u201338. https:\/\/doi.org\/10.1007\/s00210-016-1224-8.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"3732_CR78","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1089\/dna.2011.1469","volume":"31","author":"HB Kern","year":"2012","unstructured":"Kern HB, Niemeyer BF, Parrish JK, Kerr CA, Yaghi NK, Prescott JD, Gutierrez-Hartmann A, Jedlicka P. Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor\/ras signaling and Ets transcription factors. DNA Cell Biol. 2012;31(8):1403\u201311. https:\/\/doi.org\/10.1089\/dna.2011.1469.","journal-title":"DNA Cell Biol"},{"issue":"7","key":"3732_CR79","doi-asserted-by":"publisher","first-page":"101042831770643","DOI":"10.1177\/1010428317706430","volume":"39","author":"M Kunz","year":"2017","unstructured":"Kunz M, G\u00f6ttlich C, Walles T, Nietzer S, Dandekar G, Dandekar T. MicroRNA-21 versus microRNA-34: lung cancer promoting and inhibitory MicroRNAs analyzed in Silico and in vitro and their clinical impact. Tumour Biology: J Int Soc Oncodevelopmental Biology Med. 2017;39(7):1010428317706430. https:\/\/doi.org\/10.1177\/1010428317706430.","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"key":"3732_CR80","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.toxlet.2018.02.027","volume":"289","author":"L Lu","year":"2018","unstructured":"Lu L, Xu H, Yang P, Xue J, Chen C, Sun Q, Yang Q, Lu J, Shi A, Liu Q. Involvement of HIF-1\u03b1-regulated miR-21, acting via the Akt\/NF-\u03baB pathway, in malignant transformation of HBE cells induced by cigarette smoke extract. Toxicol Lett. 2018;289:14\u201321. https:\/\/doi.org\/10.1016\/j.toxlet.2018.02.027.","journal-title":"Toxicol Lett"},{"key":"3732_CR81","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.omto.2020.10.005","volume":"19","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Guo D, Zhang Y. Association of MicroRNA-21 with p53 at mutant sites R175H and R248Q, clinicopathological features, and prognosis of NSCLC. Mol Therapy Oncolytics. 2020;19:208\u201317. https:\/\/doi.org\/10.1016\/j.omto.2020.10.005.","journal-title":"Mol Therapy Oncolytics"},{"issue":"1","key":"3732_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.apjtm.2016.09.011","volume":"10","author":"Y Yang","year":"2017","unstructured":"Yang Y, Guo JX, Shao ZQ. miR-21 targets and inhibits tumor suppressor gene PTEN to promote prostate cancer cell proliferation and invasion: an experimental study. Asian Pac J Trop Med. 2017;10(1):87\u201391. https:\/\/doi.org\/10.1016\/j.apjtm.2016.09.011.","journal-title":"Asian Pac J Trop Med"},{"issue":"5","key":"3732_CR83","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.3892\/or.2018.6663","volume":"40","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Xie J, Jiang F, Li Y, Chang G, Ma H. Inhibition of miR-21 promotes cell apoptosis in oral squamous cell carcinoma by upregulating PTEN. Oncol Rep. 2018;40(5):2798\u2013805. https:\/\/doi.org\/10.3892\/or.2018.6663.","journal-title":"Oncol Rep"},{"issue":"1","key":"3732_CR84","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s41598-020-58072-w","volume":"10","author":"D Bhere","year":"2020","unstructured":"Bhere D, Arghiani N, Lechtich ER, Yao Y, Alsaab S, Bei F, Matin MM, Shah K. Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy. Sci Rep. 2020;10(1):1779. https:\/\/doi.org\/10.1038\/s41598-020-58072-w.","journal-title":"Sci Rep"},{"issue":"30","key":"3732_CR85","doi-asserted-by":"publisher","first-page":"28867","DOI":"10.18632\/oncotarget.4814","volume":"6","author":"C He","year":"2015","unstructured":"He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X. MiR-21 mediates Sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN\/Akt pathway. Oncotarget. 2015;6(30):28867\u201381. https:\/\/doi.org\/10.18632\/oncotarget.4814.","journal-title":"Oncotarget"},{"issue":"2","key":"3732_CR86","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2013.05.007","volume":"337","author":"L Bao","year":"2013","unstructured":"Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Su C, Chen J. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT\/ERK pathways. Cancer Lett. 2013;337(2):226\u201336. https:\/\/doi.org\/10.1016\/j.canlet.2013.05.007.","journal-title":"Cancer Lett"},{"issue":"1","key":"3732_CR87","doi-asserted-by":"publisher","first-page":"21906","DOI":"10.1038\/s41598-023-49225-8","volume":"13","author":"HG Kalajahi","year":"2023","unstructured":"Kalajahi HG, Yari A, Amini M, Catal T, Ahmadpour Youshanlui M, Pourbagherian O, Zhmurov CS, Mokhtarzadeh A. Therapeutic effect of microRNA-21 on differentially expressed hub genes in gastric cancer based on systems biology. Sci Rep. 2023;13(1):21906. https:\/\/doi.org\/10.1038\/s41598-023-49225-8.","journal-title":"Sci Rep"},{"issue":"19","key":"3732_CR88","doi-asserted-by":"publisher","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","volume":"68","author":"T Papagiannakopoulos","year":"2008","unstructured":"Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008;68(19):8164\u201372. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1305.","journal-title":"Cancer Res"},{"issue":"4","key":"3732_CR89","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cdtm.2016.11.012","volume":"2","author":"SN Yu","year":"2016","unstructured":"Yu SN, Ma YH, Zhao WG, Jin XL, Yang HY, Liu PP, Chen J. KRAS-related non-coding RNAs in pancreatic ductal adenocarcinoma. Chronic Dis Translational Med. 2016;2(4):215\u201322. https:\/\/doi.org\/10.1016\/j.cdtm.2016.11.012.","journal-title":"Chronic Dis Translational Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03732-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03732-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03732-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T06:13:30Z","timestamp":1740809610000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03732-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3732"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03732-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}